Skip to main content
. 2009 Jun 17;47(8):2639–2642. doi: 10.1128/JCM.00119-09

TABLE 1.

Summary of assay performance results with specimens from acutely infected and recently infected individualsa

Sample ID Initial screen First-gen or second-gen EIA
WB Third-gen EIA
OQ UG SR MS Viral load (copies/ml)b Fourth-gen IA
Avg S/C Result Avg S/C Result RT RT RT RT Avg S/CO Result
A First-gen EIA 0.351 NR I 0.127 NR N N N N 5,770† 0.37 NR
B First-gen EIA 0.602 NR I 0.955 NR N N N N ≥500,000† 611.12 R
C First-gen EIA 0.440 NR I ≥14.658 R N R N N 12,183† 1.62 R
E First-gen EIA 0.368 NR I 0.233 NR N N N N 6,373† 0.65 NR
F First-gen EIA 0.329 NR I 13.433 R N R N R1 ≥500,000† 85.73 R
G First-gen EIA 0.317 NR N 0.084 NR N N N N 12,852† 0.74 NR
H First-gen EIA 0.338 NR I 0.109 NR N N N N 14,062† 0.68 NR
I First-gen EIA 0.646 NR I ≥14.658 R R R R R1 ≥500,000† 67.70 R
J First-gen EIA 0.358 NR N 0.106 NR N N N N 3,921† 0.23 NR
K First-gen EIA 0.346 NR N 4.574 R N R N N ≥500,000† 43.92 R
L First-gen EIA 0.373 NR N 0.175 NR N R N N ≥500,000† 39.55 R
M OQ RT-FS 0.344 NR N 1.5327 R N N N N ≥500,000† 368.21 R
N First-gen EIA 0.337 NR N 0.113 NR N N N N 1,177† 0.21 NR
O OQ RT-FS 0.301 NR N 0.127 NR N N N N ≥500,000† 61.32 R
P First-gen EIA 0.755 NR N ≥14.658 R N R N R1 ≥500,000† 136.62 R
Q First-gen EIA 0.311 NR N 0.277 NR N N N N 43,173† 1.80 R
R OQ RT-FS 0.642 NR I 0.117 NR N N N N 30,734† 2.05 R
S First-gen EIA 0.406 NR N 13.276 R N R N R1 ≥500,000† 219.97 R
T OQ RT-OF 0.401 NR N 4.929 R N N N N ≥500,000† 268.30 R
U OQ RT-FS 0.325 NR N 0.195 NR N N N N ≥500,000† 317.71 R
V OQ RT-FS 0.512 NR N 0.198 NR N N N N ≥500,000† 20.53 R
W First-gen EIA 0.504 NR I ≥12.403 R N R N R1 ≥500,000† 121.68 R
Y OQ RT-FS 0.340 NR N ≥12.590 R N N N N ≥500,000† 237.06 R
Z First-gen EIA 0.378 NR N 0.201 NR N N N N 102,288† 2.09 R
AA First-gen EIA 0.343 NR N 0.327 NR N N N N 327,333† 6.34 R
AB First-gen EIA 0.373 NR N 0.189 NR N N N N ≥500,000† 168.87 R
AC OQ RT-FS 0.396 NR I 0.280 NR N N N N ≥500,000† 35.93 R
AD First-gen EIA 0.426 NR N 0.371 NR N N N N ≥500,000† 132.59 R
AE OQ RT-FS 0.369 NR N 0.145 NR N N N N 389,850† 12.24 R
AF OQ RT-FS 0.761 NR I 0.907 NR N R N R1 413,186† 13.89 R
AG Third-gen EIA 0.436 NR I 0.165 NR N N N N 446,770† 19.21 R
AH Third-gen EIA 0.371 NR N 0.195 NR N N N N 358,030† 10.66 R
AJ OQ RT-FS 0.6 NR N 1.528 R N N N N ≥500,000† 24.25 R
AK OQ RT-FS 0.6 NR N 0.147 NR N N N N 427,490† 3.45 R
AM OQ RT-FS 0.41 NR N 0.187 NR N N N N ≥500,000† 309.58 R
AN OQ RT-OF 0.33 NR N 0.17 NR N N N N ≥500,000† 17.55 R
AO Third-gen EIA 0.45 NR N 9.634 R N N N N ≥500,000† 22.83 R
AP Third-gen EIA 0.34 NR N ≥12.834 R N R N R1 ≥500,000† 131.50 R
AR OQ RT-OF 0.45 NR N 0.097 NR N N N N ≥500,000† 10.57 R
AS Third-gen EIA 0.48 NR I ≥14.641 R R R R R1 ≥500,000† 24.74 R
AT OQ RT-OF 0.40 NR N 0.174 NR N N N N ≥500,000† 176.23 R
AU OQ RT-OF 1.48 R P 13.09 R R R R R1 109,211 31.35 R
AV OQ RT-OF 0.5 NR N 0.271 NR N N N N 333,066 5.68 R
AW OQ RT-OF 5.82 R P 12.496 R R R R R1 335 14.33 R
AX OQ RT-OF 0.36 NR N 1.554 R N R N N ≥10,000,000 360.32 R
AY OQ RT-OF 0.45 NR N 0.215 NR N N N N 69,599 1.46 R
AZ OQ RT-OF 0.59 NR P 9.454 R R R R R1 2,915,309 80.82 R
BA OQ RT-OF 0.31 NR N 13.205 R N R N R1 518,434 9.13 R
BB Third-gen EIA 0.32 NR N 0.16 NR N N N N 317,609 3.81 R
BC OQ RT-OF 6.65 R P ≥13.943 R R R R R1 13,204 77.09 R
BD OQ RT-FS 0.5 NR P 10.7 R R R R R1 8,887,199 128.99 R
BE OQ RT-FS 0.38 NR I 0.243 NR N N N N ≥10,000,000 132.66 R
BF OQ RT-OF 0.34 NR N 5.443 R N N N N ≥10,000,000 430.39 R
BG OQ RT-OF 5.69 R P ≥13.514 R R R R R1 468,809 12.66 R
BH OQ RT-OF 0.35 NR N 0.232 NR N N N N 9,289,006 80.34 R
BI OQ RT-FS 2.93 R P 10.564 R R R R R1 355 3.99 R
BJ Third-gen EIA 0.346 NR I 0.123 NR N N N N 9,855 0.71 NR
BK OQ RT-OF 0.294 NR N 0.403 NR N N N N 650,629 6.08 R
BL OQ RT-OF 5.13 R P ≥14.493 R R R R R1 752 199.51 R
BM OQ RT-FS 0.326 NR N 0.345 NR N N N N 4,589,912 44.06 R
BN OQ RT-FS 2.959 R I 1.18 R R N R R1 4,571,787 48.35 R
BO OQ RT-FS 0.22 NR N 0.168 NR N N N N 1,531,891 18.05 R
BP OQ RT-FS 1.015 R N 4.139 R N R N R1 ≥10,000,000 136.82 R
BQ OQ RT-FS 0.15 NR N 0.539 NR N N N N 3,427,483 14.92 R
a

The first-generation (first-gen) EIA was the BioMérieux Vironostika HIV-1 micro-ELISA. The second-generation EIA was the Bio-Rad Genetic Systems rLAV HIV-1 EIA. The third-generation EIA was the Bio-Rad Genetic Systems HIV-1/2 plus O EIA. The fourth-generation IA was the Abbott Architect HIV Ag/Ab Combo. WB, Western blot assay using Bio-Rad Genetic Systems HIV-1; OQ RT-OF, OraQuick rapid test of oral fluid; OQ RT-FS, OraQuick rapid test of fingerstick sample; OQ-RT, Oraquick Advance HIV-1/2 rapid test; UG -RT, Uni-Gold Recombigen HIV-1 rapid test; SP-RT, Stat Pak HIV-1/2 rapid test; MS-RT, Multi-Spot HIV-1/2 rapid test. Results: R, reactive; NR, nonreactive; R1, reactive for HIV-1; P, positive; N, negative; I, indeterminate.

b

†, viral load was determined with Siemens Versant HIV-1 RNA v. 3.0 (otherwise, samples were tested using the Abbott real-time HIV-1 test).